...
首页> 外文期刊>Molecular and Cellular Endocrinology >Role of protein aggregation and degradation in autosomal dominant neurohypophyseal diabetes insipidus
【24h】

Role of protein aggregation and degradation in autosomal dominant neurohypophyseal diabetes insipidus

机译:蛋白质聚集和降解在常染色体显性神经内神经性糖尿病胰腺炎的作用

获取原文
获取原文并翻译 | 示例

摘要

This review focuses on the cellular and molecular aspects underlying familial neurohypophyseal diabetes insipidus (DI), a rare disorder that is usually transmitted in an autosomal-dominant fashion. The disease, manifesting in infancy or early childhood and gradually progressing in severity, is caused by fully penetrant heterozygous mutations in the gene encoding prepro-vasopressin-neurophysin II, the precursor of the antidiuretic hormone arginine vasopressin (AVP). Post mortem studies in affected adults have shown cell degeneration in vasopressinergic hypothalamic nuclei. Studies in cells expressing pathogenic mutants and knock-in rodent models have shown that the mutant precursors are folding incompetent and fail to exit the endoplasmic reticulum (ER), as occurs normally with proteins that have entered the regulated secretory pathway. A portion of these mutants is eliminated via ER-associated degradation (ERAD) by proteasomes after retrotranslocation to the cytosol. Another portion forms large disulfide-linked fibrillar aggregates within the ER, in which wild-type precursor is trapped. Aggregation capacity is independently conferred by two domains of the prohormone, namely the AVP moiety and the C-terminal glycopeptide (copeptin). The same domains are also required for packaging into dense-core secretory granules and regulated secretion, suggesting a disturbed balance between the physiological self-aggregation at the trans-Golgi network and avoiding premature aggregate formation at the ER in the disease. The critical role of ERAD in maintaining physiological water balance has been underscored by experiments in mice expressing wild-type AVP but lacking critical components of the ERAD machinery. These animals also develop DI and show amyloid-like aggregates in the ER lumen. Thus, the capacity of the ERAD is exceeded in autosomal dominant DI, which can be viewed as a neurodegenerative disorder associated with the formation of amyloid ER aggregates. While DI symptoms develop prior to detectable cell death in transgenic DI mice, the eventual loss of vasopressinergic neurons is accompanied by autophagy, but the mechanism leading to cell degeneration in autosomal dominant neurohypophyseal DI still remains unknown.
机译:本综述侧重于家族神经型糖尿病患者(DI)的蜂窝和分子方面,一种罕见的疾病,其通常以常染色体显性方式传播。疾病,表现在婴儿期或早期儿童早期和严重程度逐渐进展,是由编码前血管加压素 - 神经蛋白II的基因中的完全渗透杂合性突变引起的,抗血管激素精氨酸血管加压素(AVP)的前体。受影响成人的验尸研究表现出血管连接内下丘脑核中的细胞变性。表达致病性突变体和敲入啮齿动物模型的细胞的研究表明,突变前体是折叠的不称话并且不能退出内质网(ER),通常与进入调节分泌途径的蛋白质发生。通过反射转移到细胞溶溶胶溶剂术后,通过ER相关的降解(ERAD)消除这些突变体的一部分。另一部分在ER中形成大的二硫化物连接的纤维状聚集体,其中野生型前体被捕获。聚集能力独立地赋予前夸醌的两个结构域,即AVP部分和C末端糖肽(Copeptin)。包装成致密核性分泌颗粒和调节分泌也需要相同的结构域,这表明Trans-Golgi网络的生理自我聚集之间的干扰平衡,并避免了疾病中的ER在ER中的过早骨料形成。 Erad在维持生理水平方面的关键作用是通过表达野生型AVP的小鼠实验,但缺乏ERAD机械的关键部件。这些动物还在ER腔中发育了DI并显示出淀粉样蛋白状聚集体。因此,在常染色体占优势胺中超过ERAD的能力,其可以被视为与形成淀粉样蛋白ER聚集体相关的神经变性疾病。虽然在转基因DI小鼠中可检测到的细胞死亡之前发育的DI症状发生,但血管连接内耳神经元的最终丧失伴有自噬,但导致常染色体显性神经内神经性症的细胞变性的机制仍然未知。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号